Dr Corey Garvin, MD - Medicare Interventional Radiology in Augusta, GA

Dr Corey Garvin, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Augusta, Georgia. He went to University Of South Florida College Of Medicine and graduated in 2016 and has 8 years of diverse experience with area of expertise as Interventional Radiology. He is a member of the group practice St Thomas Radiology Associates Llc, Medical Imaging Center Of Ocala Llp, Radiology Imaging Associates, Llc, Inverness Medical Imaging Llc, Ocala Health Imaging Services Llc, Timberridge Imaging Center, St Thomas Radiology Associates Llc and his current practice location is 1120 15th St, Augusta, Georgia. You can reach out to his office (for appointments etc.) via phone at (352) 286-9383.

Dr Corey Garvin is licensed to practice in Georgia (license number 008261) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063861045.

Contact Information

Dr Corey Garvin, MD
1120 15th St,
Augusta, GA 30912-0004
(352) 286-9383
Not Available



Physician's Profile

Full NameDr Corey Garvin
GenderMale
SpecialityInterventional Radiology
Experience8 Years
Location1120 15th St, Augusta, Georgia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Corey Garvin attended and graduated from University Of South Florida College Of Medicine in 2016
  NPI Data:
  • NPI Number: 1063861045
  • Provider Enumeration Date: 06/09/2016
  • Last Update Date: 06/09/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 1052685229
  • Enrollment ID: I20220523002314

Medical Identifiers

Medical identifiers for Dr Corey Garvin such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063861045NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 008261 (Georgia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Marion Communtiy HospitalOcala, FLHospital
Adventhealth OcalaOcala, FLHospital
Bayfront Health Seven RiversCrystal river, FLHospital
Gov Juan F Luis Hospital & Medical CtrSt croix, VIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
St Thomas Radiology Associates Llc004223513737
Medical Imaging Center Of Ocala Llp034513078736
Radiology Imaging Associates, Llc246634280374
Inverness Medical Imaging Llc387059067266
Ocala Health Imaging Services Llc822421717931
Timberridge Imaging Center943604986334
St Thomas Radiology Associates Llc004223513737

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Corey Garvin allows following entities to bill medicare on his behalf.
Entity NameTimberridge Imaging Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669460473
PECOS PAC ID: 9436049863
Enrollment ID: O20040318000633

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Entity NameMedical Imaging Center Of Ocala Llp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669469045
PECOS PAC ID: 0345130787
Enrollment ID: O20040318000671

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Entity NameRadiology Imaging Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063400729
PECOS PAC ID: 2466342803
Enrollment ID: O20040318000719

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Entity NameInverness Medical Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093763591
PECOS PAC ID: 3870590672
Enrollment ID: O20061108000195

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Entity NameOcala Health Imaging Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023318060
PECOS PAC ID: 8224217179
Enrollment ID: O20110124001037

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Entity NameSt Thomas Radiology Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659385011
PECOS PAC ID: 0042235137
Enrollment ID: O20201204000710

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Entity NameCommunity Imaging Alliance Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194466854
PECOS PAC ID: 6305227190
Enrollment ID: O20220726001435

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Corey Garvin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Corey Garvin, MD
1120 15th St,
Augusta, GA 30912-0004

Ph: () -
Dr Corey Garvin, MD
1120 15th St,
Augusta, GA 30912-0004

Ph: (352) 286-9383

News Archive

Emanuel reassures Democrats on public insurance option

"White House Chief of Staff Rahm Emanuel reassured House Democrats on Tuesday night that President Barack Obama strongly backs a government-run health insurance plan, seeking to quell a firestorm among liberals upset at Emanuel's comments in the Wall Street Journal that suggested such a plan could be delayed," Roll Call reports.

Obama's next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program' to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

Read more News

› Verified 7 days ago


Radiology Doctors in Augusta, GA

Michael A Winkler, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1120 15th St, Augusta, GA 30912
Phone: 706-721-8623    
Jagadishwar Devkota, M.D.
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 20 Winged Foot Dr, Augusta, GA 30907
Phone: 706-414-8235    Fax: 706-364-2606
Paul N. Karmin, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 1120 15th St, Augusta, GA 30912
Phone: 706-721-9729    Fax: 706-721-8507
Juhi Bansal,
Radiology
Medicare: Medicare Enrolled
Practice Location: 1120 15th St, Augusta, GA 30912
Phone: 706-721-2273    
Dr. William Bruce Tannehill, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 630 13th St, Suite 250, Augusta, GA 30901
Phone: 706-724-2500    Fax: 706-823-5928
Dr. Kandace Rhea Klein, D.O.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1120 15th St, Ba-1411, Augusta, GA 30912
Phone: 706-721-3233    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.